Utah Medical Products files 8-K with Q2 2025 results; specifics not extractable from filed text

UTAH MEDICAL PRODUCTS INC

2025-Q2 EPS reported $1.86 revenue$19,663,000

Press release dated July 24, 2025 covers three and six months ended June 30, 2025.
No financial figures (revenue, EPS, net income) were included in the provided filing excerpt.
The filing is furnished under Item 2.02 and includes forward-looking statements.
Investors should consult the full Exhibit 99.1 press release for actual results.

item 2.02item 9.01item 99.1

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.